Point72 Hong Kong LTD Chimerix Inc Transaction History

Point72 Hong Kong LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$4.58 - $6.8 $23,362 - $34,686	-5,101 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$5.23 - $7.18 $1,642 - $2,254	314 Added 6.56%	5,101 $33,000
Q3 2021 Nov 15, 2021	SELL	$5.94 - $8.75 $36,477 - $53,733	-6,141 Reduced 56.2%	4,787 $30,000
Q2 2021 Aug 16, 2021	BUY	$7.54 - $9.79 $82,397 - $106,985	10,928 New	10,928 $87,000
Q1 2020 May 15, 2020	SELL	$1.27 - $2.33 $6,478 - $11,885	-5,101 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$1.3 - $2.72 $6,292 - $13,164	4,840 Added 1854.41%	5,101 $10,000
Q3 2019 Nov 14, 2019	BUY	$1.93 - $4.21 $503 - $1,098	261 New	261 $1,000
Q1 2019 May 15, 2019	SELL	$1.79 - $3.12 $93 - $162	-52 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$3.58 - $4.9 $186 - $254	52 New	52 $0

36.8M

72.2K

169K

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $85M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.